Phase 3 Study of Acupression's Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy's Sort.

Inclusion Criteria: Woman Age > 18 years Well-informed written consent, signed by the patient before the beginning of the study Breast cancer's diagnosis (operated or not) Forecast of a treatment by FEC100 chemotherapy's sort (D1=D21) during at least 3 cycles. Patient affiliated at a welfare or beneficiary from it Investigator estimates that the patient is able to conform with protocol's conditions and to respect them Exclusion Criteria: Operated arm's lymphedema Wrist's morphology which cannot permit the bracelet's wearing (20 cm) D1=D15 FEC100's treatment Psychic incapability to sign a well-informed consent Refusal to give a written consent Patient under tutelage or guardianship Pregnant or breast-feeding woman Any clinical trial's participation which would impose nausea and vomiting's treatment modalities